Massive pulmonary embolism in pregnancy treated with catheter-directed tissue plasminogen activator. uri icon

Overview

abstract

  • Pulmonary embolism is a leading cause of maternal death in the United States, contributing to the death of approximately 2 women per 100,000 live births each year. Thrombosis during pregnancy traditionally is treated conservatively with unfractionated heparin or low-molecular-weight heparin; however, cardiovascular collapse associated with a large pulmonary embolus may require immediate aggressive intervention to save the mother and fetus. We report the use of catheter infusion thrombolysis in the successful management of a third-trimester pregnant patient with a hemodynamically significant saddle pulmonary embolus.

publication date

  • April 1, 2015

Research

keywords

  • Fibrinolytic Agents
  • Pulmonary Embolism
  • Thrombolytic Therapy
  • Tissue Plasminogen Activator

Identity

Scopus Document Identifier

  • 84941360489

Digital Object Identifier (DOI)

  • 10.1213/XAA.0000000000000128

PubMed ID

  • 25827861

Additional Document Info

volume

  • 4

issue

  • 7